International Immunology, Vol. 11, No. 3, 461-469,
March 1999
© 1999 Japanese Society for Immunology
CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes
Louis-Jeantet Laboratory of Molecular Genetics, Department of Genetics and Microbiology, University of Geneva Medical School, CMU, 9 Avenue de Champel, 1211 Geneva 4, Switzerland
Correspondence to: J. Villard
Precise regulation of MHC class II expression plays a crucial role in the control of the immune response. The transactivator CIITA behaves as a master controller of constitutive and inducible MHC class II gene activation, but its exact mechanism of action is not known. Activation of MHC class II promoters requires binding of at least three distinct multi-protein complexes (RFX, X2BP and NF-Y). It is known that the stability of this binding results from cooperative interactions between these proteins. We show here that expression of CIITA in MHC class II– cells triggers occupation of the promoters by these complexes. This observation raised the possibility that the effect of CIITA on promoter occupation is mediated by an effect on the cooperative stabilization of the DNA-bound multi-protein complexes. We show, however, that the presence of CIITA does not affect the stability of the higher-order protein complex formed on DNA by RFX, X2BP and NF-Y. This suggests other mechanisms for CIITA-induced promoter occupancy, such as an effect on chromatin structure leading to increased accessibility of MHC class II promoters. This ability of CIITA to facilitate promoter occupation is undissociable from its transactivation potential. Finally, we conclude that this effect of CIITA is cell-type specific, since expression of CIITA is not required for normal occupation of MHC class II promoters in B lymphocytes.
Keywords: CIITA, MHC class II, multi-protein complex, stabilization
Transmitting editor: H. R. MacDonald
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Leimgruber, Q. Seguin-Estevez, I. Dunand-Sauthier, N. Rybtsova, C. D. Schmid, G. Ambrosini, P. Bucher, and W. Reith Nucleosome eviction from MHC class II promoters controls positioning of the transcription start site Nucleic Acids Res., May 1, 2009; 37(8): 2514 - 2528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Buttice, J. Miller, L. Wang, and B. D. Smith Interferon-{gamma} Induces Major Histocompatibility Class II Transactivator (CIITA), Which Mediates Collagen Repression and Major Histocompatibility Class II Activation by Human Aortic Smooth Muscle Cells Circ. Res., March 3, 2006; 98(4): 472 - 479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Osborne, H. Zhang, G. Fejer, K. M. Palubin, M. I. Niesen, and G. Blanck Oct-1 Maintains an Intermediate, Stable State of HLA-DRA Promoter Repression in Rb-defective Cells: AN Oct-1-CONTAINING REPRESSOSOME THAT PREVENTS NF-Y BINDING TO THE HLA-DRA PROMOTER J. Biol. Chem., July 9, 2004; 279(28): 28911 - 28919. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Raval, J. D. Weissman, T. K. Howcroft, and D. S. Singer The GTP-Binding Domain of Class II Transactivator Regulates Its Nuclear Export J. Immunol., January 15, 2003; 170(2): 922 - 930. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Barbieri, V. Deffrennes, T. Prod'homme, J. Vedrenne, F. Baton, C. Cortes, A. Fischer, M.-R. Bono, B. Lisowska-Grospierre, D. Charron, et al. Isoforms of the class II transactivator protein Int. Immunol., August 1, 2002; 14(8): 839 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Magner, A. L. Kazim, C. Stewart, M. A. Romano, G. Catalano, C. Grande, N. Keiser, F. Santaniello, and T. B. Tomasi Activation of MHC Class I, II, and CD40 Gene Expression by Histone Deacetylase Inhibitors J. Immunol., December 15, 2000; 165(12): 7017 - 7024. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Spilianakis, J. Papamatheakis, and A. Kretsovali Acetylation by PCAF Enhances CIITA Nuclear Accumulation and Transactivation of Major Histocompatibility Complex Class II Genes Mol. Cell. Biol., November 15, 2000; 20(22): 8489 - 8498. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Tierney, H. Kirby, J. Nagra, A. Rickinson, and A. Bell The Epstein-Barr Virus Promoter Initiating B-Cell Transformation Is Activated by RFX Proteins and the B-Cell-Specific Activator Protein BSAP/Pax5 J. Virol., November 15, 2000; 74(22): 10458 - 10467. [Abstract] [Full Text]
|
|
|
|
|
|
J. A. Harton and J. P.-Y. Ting Class II Transactivator: Mastering the Art of Major Histocompatibility Complex Expression Mol. Cell. Biol., September 1, 2000; 20(17): 6185 - 6194. [Full Text]
|
|
|
|
 |
|
 K. Masternak, A. Muhlethaler-Mottet, J. Villard, M. Zufferey, V. Steimle, and W. Reith CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex Genes & Dev., May 1, 2000; 14(9): 1156 - 1166. [Abstract] [Full Text]
|
|